HepatologyNews.net

Hepatology Xagena

Xagena Mappa
Medical Meeting
XagenaNewsletter
Farmaexplorer.it

Researchers at Cedars-Sinai Medical Center and 50 other Centers found that weight-based dosing of Taribavirin ( Viramidine ) reduces rates of anemia while increasing sustained virologic response ( SVR ...


A new study has found that patients with severe portal-hypertensive bleeding who are treated with Terlipressin ( Glypressin ) may experience an acute reduction of sodium in their blood.This reduction ...


Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study published in Gastroenterology.This is the first time a study evaluating the combin ...


For patients with the most common form of hepatitis C, the addition of a hepatitis C–specific protease inhibitor called Telaprevir to the current standard therapy can significantly improve the chances ...


Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer.Hypothyroidism is the most common thyroid disorder among US adults, affecting between 8 and 12 percen ...


Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers.The study found ...


Researchers at The University of Texas MD Anderson Cancer Center have discovered that exposure to the hepatitis B virus ( HBV ) may increase the risk of pancreatic cancer.The study, published in the J ...


Final results from the REPEAT study have demonstrated that treatment with once-weekly Pegasys ( Peginterferon alfa-2a ) and daily Copegus ( Ribavirin ) can achieve viral clearance in a number of patie ...


Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma of 20 percent to 30 percent, and a three-fold increase in the risk of another type of lymphoma. The prevalence of ...


For liver transplant recipients without hepatitis C ( HCV ), survival has improved over time. However, for recipients with HCV, survival has not improved. HCV-induced liver disease is the most comm ...


Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis.As liver disease progresses, fibrosis leads to portal hyper ...


A study on risk factors of new-onset diabetes following liver transplant found that a history of obesity, impaired fasting glucose and hepatitis C infection ( HCV ) paired with the use of a particular ...


Individuals with chronic hepatitis C being treated with Interferon ( IFN ) are at risk of developing retinopathy as early as two weeks into treatment according to the results of a study published in t ...


The FDA ( Food and Drug Administration ) has announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients. HepaGam B is an immune globulin ...


Hepatic fibrosis, the common response associated with chronic liver diseases, ultimately leads to cirrhosis. Researchers showed that activation of hepatic cannabinoid CB2 receptors limits progression ...